Prescription drug · ANDA
Bexarotene NDC 69238-2088
Bexarotene 10 mg/g · Gel · Topical · Amneal Pharmaceuticals NY LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69238-2088-6 | 69238208806 | 1 TUBE in 1 CARTON (69238-2088-6) / 60 g in 1 TUBEMarketed from May 4, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bexarotene
- Generic name (nonproprietary)
- bexarotene
- Active ingredients
- Bexarotene — 10 mg/g
- Dosage form
- Gel
- Route
- Topical
- Labeler
- Amneal Pharmaceuticals NY LLCNDC labeler code 69238
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215398
- Marketing start
- Listing expires
- Other FDA classes
- Retinoids (Chemical structure)
- Identifiers
- Product ID 69238-2088_e90bb84a-0b45-4163-92da-d8ed239a0b1dSPL ID e90bb84a-0b45-4163-92da-d8ed239a0b1dSPL set ID 2c21f361-e3d1-45a5-a6e7-df8164e3f90dRxCUI 308724UNII A61RXM4375UPC 0369238208863
- Pharmacologic class
- Retinoid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469238208806followed by a unit qualifier and the quantityPackage 69238-2088-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Bexarotene gel, 1% is indicated for the topical treatment of cutaneous lesions in patients with CTCL (Stage IA and IB) who have refractory or persistent disease after other therapies or who have not tolerated other therapies.
Excerpt only. Read the full label for complete information.
About NDC 69238-2088
- What is NDC 69238-2088?
- 69238-2088 is the product NDC for Bexarotene, Bexarotene 10 mg/g gel, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Bexarotene.
- What is the active ingredient?
- Bexarotene.
- Who is the labeler?
- Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Bexarotene?
- 7 other product NDCs are listed under this name. See all Bexarotene NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Bexarotene products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | Camber Pharmaceuticals, Inc. | 31722-380 | 31722-0380-01 |
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | AvKARE | 42291-072 | 42291-0072-01 |
| bexarotene | Bexarotene 75 mg/1 | Capsule, Liquid filledOral | Actavis Pharma, Inc. | 0591-2832 | 00591-2832-01 |
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1250 | 69238-1250-01 |
| Bexarotene | Bexarotene 75 mg/1 | CapsuleOral | Upsher-Smith Laboratories, Inc. | 0832-0285 | 00832-0285-00 |
| Bexarotene | Bexarotene 75 mg/1 | Capsule, Liquid filledOral | ANI Pharmaceuticals, Inc. | 43975-315 | 43975-0315-10 |
| Bexarotene | Bexarotene 75 mg/1 | Capsule, Liquid filledOral | Mylan Pharmaceuticals Inc. | 0378-6955 | 00378-6955-01 |